October

October 25, 2014

Interleukin-based therapy for Metabolic disorders: c-Myc increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 25/October/2014, 11.26

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Interleukin-based therapy for Metabolic disorders: c-Myc increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up […]
October 25, 2014

Mechanism of tumorigenesis: RREB increases the expression of Notch-1 and -2 via down regulation of its target gene, 25/October/2014, 11.13 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Mechanism of tumorigenesis: RREB increases the expression of Notch-1 and -2 via down regulation of its target gene, 25/October/2014, 11.13 am, Genome-2-Bio-Medicine Discovery […]
October 25, 2014

Natural product-based therapy for Hypertension: Silvestrol rescues pulmonary arterial hypertension via down regulation of its target gene, 25/October/2014, 11.07 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Natural product-based therapy for Hypertension: Silvestrol rescues pulmonary arterial hypertension via down regulation of its target gene, 25/October/2014, 11.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org […]
October 25, 2014

Natural product-based therapy for DM: Mangiferin, a compound isolated from Mango, inhibits gluconeogenesis and hyperglycemia via up regulation of Cyclin D1, 25/September/2014, 11.03 am

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, Boston, Massachusetts, USA; and others shows that “Cyclin D1–Cdk4 controls glucose metabolism independently of […]